Homology Medicines Inc (FIXX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Albert Seymour
Employees:
220
45 WIGGINS AVE., BEDFORD, MA 01730
857-305-1825

Homology Medicines, Inc. focuses on transforming the lives of patients suffering from rare genetic diseases. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues.

Data derived from most recent annual or quarterly report
Market Cap 56.352 Million Shares Outstanding57.678 Million Avg 30-day Volume 95.343 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.2
Price to Revenue18.5311 Debt to Equity0.0 EBITDA-124.898 Million
Price to Book Value0.3914 Operating Margin-3839.5885 Enterprise Value-113.613 Million
Current Ratio8.299 EPS Growth-17.167 Quick Ratio8.106
1 Yr BETA 1.4 52-week High/Low 3.3 / 0.86 Profit Margin-3926.2469
Operating Cash Flow Growth1.4293 Altman Z-Score-3.6833 Free Cash Flow to Firm -54.932 Million
Earnings Report2023-08-14
View SEC Filings from FIXX instead.

View recent insider trading info

Funds Holding FIXX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FIXX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-01-04:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-08:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-06-13:
    Item 8.01: Other Events
  • 8-K: filed on 2022-04-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-16:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-18:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-21:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-04-12:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-04-09:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    JORDAN JULIE CHIEF MEDICAL OFFICER

    • Officer
    2,519 2023-03-07 1

    ALLOWAY PAUL SEE REMARKS

    • Officer
    16,706 2023-03-02 5

    SMITH W BRADFORD SEE REMARKS

    • Officer
    0 2023-02-23 3

    SEYMOUR ALBERT SEE REMARKS

    • Officer
    • Director
    0 2023-02-23 5

    BLUM MICHAEL LEE CHIEF COMMERCIAL OFFICER

    • Officer
    0 2023-02-23 4

    TZIANABOS ARTHUR

    • Director
    108,395 2023-01-09 2

    GILLIS STEVEN

    • Director
    18,000 2022-06-15 1

    THISTLE MARY

    • Director
    18,000 2022-06-15 1

    PATTERSON MATTHEW R

    • Director
    18,000 2022-06-15 1

    GREGORY RICHARD J.

    • Director
    18,000 2022-06-15 1

    PARMAR KUSH

    • Director
    18,000 2022-06-15 1

    REICIN ALISE

    • Director
    18,000 2022-06-15 1

    POULTON JEFFREY V.

    • Director
    18,000 2022-06-15 1

    KELLY TIMOTHY P CHIEF OPERATING OFFICER

    • Officer
    33,000 2022-02-24 0

    COHN GABRIEL CHIEF MEDICAL OFFICER

    • Officer
    15,629 2022-01-01 0

    5AM VENTURES IV, L.P.

    5AM CO-INVESTORS IV, L.P.

    5AM PARTNERS IV, LLC

    DIEKMAN JOHN D

    ROCKLAGE SCOTT M

    SCHWAB ANDREW J.

    • 10% Owner
    No longer subject to file 2020-12-22 0

    FLYNN JAMES E

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD MGMT L.P.

    DEERFIELD PARTNERS, L.P.

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    DEERFIELD MGMT III, L.P.

    DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

    DEERFIELD MGMT HIF, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    No longer subject to file 2020-01-29 0

    RASTY SIYAMAK CHIEF OPERATING OFFICER

    • Officer
    222,707 2019-07-09 0

    FLYNN JAMES E

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    • Director
    • 10% Owner
    • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
    0 2019-06-06 0

    WHEELER CAMERON

    • Director
    0 2019-06-06 0

    ARCH VENTURE FUND VIII, L.P.

    ARCH VENTURE FUND VIII OVERAGE, L.P.

    ARCH VENTURE PARTNERS VIII, L.P.

    ARCH VENTURE PARTNERS VIII, LLC

    BYBEE CLINTON

    CRANDELL KEITH

    NELSEN ROBERT

    • 10% Owner
    5,768,694 2019-05-21 0

    5AM VENTURES IV, L.P.

    5AM PARTNERS IV, LLC

    ROCKLAGE SCOTT M

    DIEKMAN JOHN D

    SCHWAB ANDREW J.

    5AM CO-INVESTORS IV, L.P.

    5AM VENTURES IV, L.P.

    5AM PARTNERS IV, LLC

    ROCKLAGE SCOTT M

    DIEKMAN JOHN D

    SCHWAB ANDREW J.

    5AM CO-INVESTORS IV, L.P.

    • 10% Owner
    12,301,838 2018-12-10 0

    TEMASEK HOLDINGS (PRIVATE) LTD

    FULLERTON MANAGEMENT PTE LTD

    TEMASEK LIFE SCIENCES PRIVATE LTD

    TLS BETA PTE. LTD.

    V-SCIENCES INVESTMENTS PTE LTD

    • 10% Owner
    No longer subject to file 2018-04-02 0

    NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

    NOVARTIS AG

    • 10% Owner
    No longer subject to file 2018-04-02 0

    SHAH MAHENDRA

    • Director
    909,742 2018-04-02 0

    ROCK SPRINGS CAPITAL MANAGEMENT LP

    ROCK SPRINGS CAPITAL MASTER FUND LP

    ROCK SPRINGS CAPITAL LLC

    • 10% Owner
    No longer subject to file 2018-04-02 0

    VIDA VENTURES, LLC

    VV MANAGER LLC

    • 10% Owner
    No longer subject to file 2018-04-02 0

    TLS BETA PTE. LTD.

    TEMASEK LIFE SCIENCES PRIVATE LTD

    FULLERTON MANAGEMENT PTE LTD

    TEMASEK HOLDINGS (PRIVATE) LTD

    • 10% Owner
    0 2018-03-28 0

    FLYNN JAMES E

    DEERFIELD MGMT HIF, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

    DEERFIELD MGMT III, L.P.

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    • Director
    • 10% Owner
    • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
    0 2018-03-27 0

    VIDA VENTURES, LLC

    • 10% Owner
    0 2018-03-27 0

    CHATTERJEE SASWATI

    • 10% Owner
    475,014 2018-03-27 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 22:15:04 UTC 2.315 2.755 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 21:45:04 UTC 2.315 2.755 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 21:15:05 UTC 2.315 2.755 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 20:45:03 UTC 2.315 2.755 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 20:15:04 UTC 2.315 2.755 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 19:45:03 UTC 2.315 2.755 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 19:15:04 UTC 2.315 2.755 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 18:45:03 UTC 2.315 2.755 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 18:15:04 UTC 2.315 2.755 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 17:45:04 UTC 2.315 2.755 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 17:15:04 UTC 2.315 2.755 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 16:45:04 UTC 2.3412 2.7188 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 16:15:04 UTC 2.3412 2.7188 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 15:45:03 UTC 2.3412 2.7188 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 15:15:04 UTC 2.3412 2.7188 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 14:45:04 UTC 2.3412 2.7188 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 14:15:04 UTC 2.3412 2.7188 300000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 13:45:04 UTC 2.3412 2.7188 250000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 13:15:04 UTC 2.3412 2.7188 250000
    HOMOLOGY MEDICINES INC FIXX 2023-06-01 12:45:04 UTC 2.3412 2.7188 250000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Enhanced Index Plus Fund FIXX -110.0 shares, $-1709.4 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund FIXX -149.0 shares, $-2315.46 2020-03-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund FIXX -2500.0 shares, $-2575.0 2023-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments